I do not have any shame in making the assessment the company can absolutely still be approved upon presentation of further analysis.
As I've said before, manage your risk.
Finally, I will use the upcoming CC as a way to confirm or reassess the potential for Anavex's approval at the EMA. I have drafted a series of questions that will make this very clear (IMO).